LENZ

LENZ

USD

LENZ Therapeutics Inc. Common Stock

$28.050+1.120 (4.159%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$26.930

Máximo

$28.400

Mínimo

$26.790

Volumen

0.68M

Fundamentos de la Empresa

Capitalización de Mercado

849.1M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.80M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $16.535Actual $28.050Máximo $50.4

Noticias Relacionadas

GlobeNewswire

LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025

SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (NASDAQ:LENZ), a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and

Ver más
LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025
Analyst Upgrades

Piper Sandler Maintains Overweight on LENZ Therapeutics, Raises Price Target to $67

Piper Sandler analyst Biren Amin maintains LENZ Therapeutics with a Overweight and raises the price target from $51 to $67.

Ver más
Piper Sandler Maintains Overweight on LENZ Therapeutics, Raises Price Target to $67